Skip to content

A Prospective, Multicenter, Randomized Controlled Clinical Study of the Safety and Efficacy of Single-Use Intracardiac Ultrasound Imaging Catheters

A Prospective, Multicenter, Randomized Controlled Clinical Study of the Safety and Efficacy of Single-Use Intracardiac Ultrasound Imaging Catheters

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099249
Enrollment
Unknown
Registered
2025-03-20
Start date
2024-09-23
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ultrasound imaging of the heart and the large vessels of the heart and intracardiac anatomy

Interventions

Test group:single-use intracardiac ultrasound imaging catheter, portable digital color ultrasound diagnostic instrument, three-dimensional cardiac electrophysiology calibration system
Control group:3D Diagnostic Ultrasound catheter SOUNDSTAR 3D Diagnostic Ultrasound catheter and its accompanying ultrasound system

Sponsors

The First Affiliated Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.18 years old<=age<=80 years old, gender is not limited; 2.Patients who plan to undergo arrhythmia interventional surgery and need to complete ultrasound imaging of the heart, cardiac large vessels, and intracardiac anatomy; 3.Fully understand the treatment plan, and voluntarily sign the informed consent form, and be willing to undergo the examination, surgery and follow-up required by the plan.

Exclusion criteria

Exclusion criteria: 1.Patients with thromboembolic disease; 2.Angina CCS grade IV or NYHA grade IV; 3.Those with definite acute cerebrovascular diseases (including cerebral hemorrhage, stroke, transient ischemic attack) in the past 1 month; 4.Those who have had cardiovascular events in the past 3 months (including acute myocardial infarction, heart bypass surgery, prosthetic valve replacement or repair, atrial or ventriculotomy); 5.Patients with acute or severe systemic infection; 6.Patients with severe liver and kidney diseases, malignant tumors and end-stage diseases, which in the opinion of the investigator may interfere with the treatment, evaluation and compliance of this trial; 7.Patients with obvious bleeding tendency, hypercoagulable state and severe hematologic diseases; 8.Patients who are participating in other clinical trials; 9.Patients who have other conditions that the investigator considers inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Ultrasound image quality rate;

Secondary

MeasureTime frame
Surgical success rate;Ultrasound catheter magnetic localization accuracy;Evaluation of Doppler flow imaging;Evaluation of test group catheter performance;

Countries

China

Contacts

Public ContactChu Huimin

The First Affiliated Hospital of Ningbo University

markchu@126.com+86 135 6633 6742

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026